KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 2 filers reported holding KYMERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,094 | -39.5% | 1,805,346 | 0.0% | 1.08% | -16.3% |
| Q2 2023 | $41,505 | -22.4% | 1,805,346 | 0.0% | 1.29% | -59.5% |
| Q1 2023 | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
| Q4 2022 | $49,920 | -99.8% | 2,000,000 | +33.3% | 2.79% | +99.9% |
| Q3 2022 | $32,655,000 | +65.8% | 1,500,000 | +50.0% | 1.39% | +32.5% |
| Q2 2022 | $19,690,000 | -53.5% | 1,000,000 | 0.0% | 1.05% | -40.6% |
| Q1 2022 | $42,320,000 | -33.3% | 1,000,000 | 0.0% | 1.77% | +2.8% |
| Q4 2021 | $63,490,000 | +170.2% | 1,000,000 | +150.0% | 1.72% | +227.6% |
| Q3 2021 | $23,496,000 | +93.8% | 400,000 | +60.0% | 0.53% | +113.8% |
| Q2 2021 | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% |
| Q1 2021 | $9,715,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.3% |
| Q4 2020 | $15,500,000 | +91.9% | 250,000 | 0.0% | 0.33% | +69.9% |
| Q3 2020 | $8,078,000 | – | 250,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |